Syphilis
MONDO:0005976A contagious bacterial infection caused by the spirochete Treponema pallidum. It is a sexually transmitted disorder, although it can also be transmitted from the mother to the fetus in utero. Typically, it is initially manifested with a single sore which heals without treatment. If the infection is left untreated, the initial stage is followed by skin rash and mucous membrane lesions. A late stage follows, which is characterized by damage of the internal organs, including the nervous system.
Also known as: Treponema pallidum caused disease or disorder, Treponema pallidum disease or disorder, Treponema pallidum infectious disease
62 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could oral antibiotics replace hospital stays for Syphilis-Exposed newborns?
Disease control Recruiting nowThis study tests whether oral antibiotics (linezolid or amoxicillin) can effectively treat newborns at risk of congenital syphilis, compared to a standard penicillin shot. The goal is to find a safe, outpatient-friendly option that avoids long hospital stays. The trial involves 9…
Phase: PHASE2 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could adding a common antibiotic beat syphilis in HIV patients?
Disease control Recruiting nowThis study tests whether adding doxycycline to the standard penicillin shot works better for treating early syphilis in people with HIV. About 688 adults will be randomly assigned to get either penicillin alone or penicillin plus a week of doxycycline pills. The main goal is to s…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New antibiotic cocktail aimed at Drug-Resistant infections in babies
Disease control Recruiting nowThis study tests a combination of two antibiotics, aztreonam and avibactam, in newborns and infants up to 9 months old who have serious infections caused by gram-negative bacteria. The trial has two parts: one to see how a single dose moves through the body, and another to test m…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a common ED drug and cycling help kids with duchenne?
Disease control Recruiting nowThis study is testing whether a drug called tadalafil (often used for erectile dysfunction) combined with a home cycling program can help boys with Duchenne muscular dystrophy. The drug aims to improve blood flow to muscles, which is often poor in DMD, while exercise builds stren…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a pill replace the shot for syphilis?
Disease control Recruiting nowThis study compares two antibiotics for treating early syphilis: a single penicillin shot (standard care) versus a 14-day course of cefixime pills. Researchers want to see if the pill works just as well. The study includes 400 adults with early syphilis, including those with well…
Phase: PHASE3 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New study offers free STI care to black youth in the deep south
Disease control Recruiting nowThis study provides free testing for chlamydia, gonorrhea, syphilis, and HIV to Black youth aged 15-26 in New Orleans. Those who test positive can get treatment at no cost and are encouraged to bring their partners. The goal is to reduce STI rates and health disparities in this c…
Phase: NA • Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Laser breakthrough? new trial aims to save sight in diabetic patients
Disease control Recruiting nowThis study tests a micropulse laser for diabetic macular edema, a condition causing vision loss in people with diabetes. Fifty participants with initial or stubborn swelling will receive the laser treatment. Researchers will measure changes in vision and retinal thickness to see …
Sponsor: The General Authority for Teaching Hospitals and Institutes • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Mass STI treatment or pill after sex? major trial tests best bet for kenyan men
Disease control Recruiting nowThis trial tests two strategies to control sexually transmitted infections (STIs) among 2,900 cisgender men who have sex with men in Kenya. One group gets a single dose of antibiotics every few months (WHO-recommended periodic presumptive treatment), another takes doxycycline wit…
Phase: PHASE4 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Double antibiotic attack: could a Two-Drug combo beat severe infections faster?
Disease control Recruiting nowThis study tests whether adding a second antibiotic (fosfomycin) to the standard antibiotic (ceftazidime) helps people with severe gram-negative infections recover faster. About 100 hospitalized adults will be randomly assigned to get either the combo or the standard drug plus a …
Phase: PHASE3 • Sponsor: Angela HUTTNER • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Five-Minute Finger-Prick test could speed syphilis diagnosis in pregnancy
Diagnosis Recruiting nowThis study tests whether a rapid finger-prick blood test for syphilis and HIV can be used in a prenatal clinic for pregnant people at risk. The test gives results in five minutes, potentially speeding up diagnosis and treatment. Participants will provide feedback on their experie…
Phase: NA • Sponsor: McMaster University • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
ER syphilis screening for pregnant women could save lives
Diagnosis Recruiting nowThis study aims to increase syphilis testing and treatment for pregnant women who haven't had prenatal care or a syphilis test during their pregnancy. Researchers will offer rapid point-of-care tests in the emergency department and obstetrical triage, then help connect those who …
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New rapid test could detect three infections at once
Diagnosis Recruiting nowThis study is testing a new rapid diagnostic device called TruPlex that can detect HIV, Hepatitis B, and Syphilis from a small blood sample. Researchers will enroll 1000 adults at risk for these infections to see how accurate and easy the test is to use in clinics and point-of-ca…
Phase: NA • Sponsor: bioLytical Laboratories • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Could new syphilis tests speed up diagnosis?
Diagnosis Recruiting nowThis study is testing two new blood test kits designed to diagnose syphilis. Researchers will collect blood samples from 1000 people, including those with symptoms, those at high risk, and healthy controls. The goal is to see how accurate these new kits are compared to standard l…
Sponsor: American Laboratory Products Company • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
One test, four diseases: could this be the end of missed diagnoses?
Diagnosis Recruiting nowThis study tests a new device called MagIA H3S that can screen for HIV, hepatitis B, hepatitis C, and syphilis using a single blood sample. Researchers will enroll about 2,950 people in Ivory Coast and Kenya to see how accurate the device is compared to standard lab tests. If it …
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Can a simple finger-prick test help find hidden HIV and syphilis cases?
Diagnosis Recruiting nowThis study checks if a new self-test for HIV and syphilis is accurate and easy for people to use at home. About 900 adults in Canada will try the test and compare results to lab tests. The study also looks at how peer support can help homeless people in Toronto get tested and tre…
Phase: NA • Sponsor: Unity Health Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Quick syphilis test could save lives: ottawa study seeks 1,300 volunteers
Diagnosis Recruiting nowThis study is testing a new rapid test for syphilis that uses a fingerstick blood sample, giving results quickly at the clinic. Researchers want to see if this quick test is as accurate as the standard lab test. About 1,300 people visiting the Ottawa Sexual Health Clinic who need…
Phase: NA • Sponsor: MedMira Laboratories Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Could new DNA tests spot syphilis in newborns faster?
Diagnosis Recruiting nowThis study is testing two new molecular tests (qPCR and TMA) to detect syphilis in pregnant women and their newborns. Researchers will compare these tests to current CDC guidelines to see if they are more accurate. The goal is to improve diagnosis and prevent congenital syphilis,…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
Penicillin shots tested to stop syphilis in pregnancy
Prevention Recruiting nowThis study tests whether giving penicillin shots to pregnant women at high risk for syphilis can prevent infection. Researchers in Rio de Janeiro will enroll 500 women and compare the shots to standard care. Participants receive monthly injections and tests during their third tri…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Antibiotic shield: doxycycline may stop STIs in young women
Prevention Recruiting nowThis study tests whether taking the antibiotic doxycycline can prevent bacterial sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis in adolescent and young adult females. About 760 participants aged 13-29 who have had an STI in the past year and recent…
Phase: PHASE4 • Sponsor: Westat • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
Rio study tests antibiotic after sex to stop STIs
Prevention Recruiting nowThis study tests whether taking the antibiotic doxycycline shortly after sex can prevent bacterial STIs like syphilis, gonorrhea, and chlamydia. It involves 200 men, transgender women, and travestis in Rio de Janeiro who are at higher risk. Participants choose whether to use doxy…
Phase: NA • Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Could a single antibiotic dose after sex stop STIs?
Prevention Recruiting nowThis study tests whether taking a single 200 mg dose of doxycycline within 24–72 hours after unprotected sex can prevent gonorrhea, chlamydia, and syphilis in men who have sex with men. Researchers in Bangkok will enroll 400 participants and follow them for 12 weeks. If effective…
Phase: PHASE4 • Sponsor: Bangrak STIs Center • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
Could STI testing be the key to getting more women on HIV prevention?
Prevention Recruiting nowThis study in Uganda tests whether adding lab tests for common sexually transmitted infections (STIs) to standard HIV risk screening helps more women start and stick with PrEP, a daily pill that prevents HIV. About 4,500 HIV-negative women aged 15-39 will be randomly assigned to …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 26, 2026 16:59 UTC
-
Can a daily supplement ease the toll of duchenne muscular dystrophy?
Symptom relief Recruiting nowThis pilot study tests whether VM100, a nutritional supplement made from ten natural ingredients, can improve quality of life for people with Duchenne muscular dystrophy (DMD). About 20 participants aged 8 and older will take VM100 or a placebo for 10 weeks. Researchers will meas…
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Aug 18, 2026 02:00 UTC
-
Quick fingerprick test could curb infection spread in rural west virginia
Knowledge-focused Recruiting nowThis study looks at whether a rapid fingerstick test that gives results in 10-20 minutes can help more people get screened for HIV, hepatitis C, and syphilis during mobile clinic visits. About 200 patients of the WVU Street Medicine team can choose the rapid test, a traditional b…
Sponsor: West Virginia University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Pregnant women needed for antibiotic safety study
Knowledge-focused Recruiting nowThis study looks at how two antibiotics, ceftriaxone and benzathine penicillin G, are processed by the body during pregnancy. Up to 78 pregnant women in the U.S. will take one of these drugs as part of their regular care, and researchers will measure drug levels in their blood. T…
Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Hidden syphilis: new study targets silent spread in women and straight men
Knowledge-focused Recruiting nowThis study aims to understand how syphilis bacteria spread from people without visible symptoms, focusing on women and men who have sex with women only—groups often overlooked in past research. Researchers will collect swabs and blood samples from 480 participants with early syph…
Sponsor: Monash University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New study tracks hidden infections in migrants
Knowledge-focused Recruiting nowThis study looks at how common certain infections are among 250 asylum seekers living in reception centers in Italy. Participants must be adults who arrived in Italy between 2 and 36 months ago. The goal is to better understand infection rates to improve health screening and care…
Phase: NA • Sponsor: IRCCS Sacro Cuore Don Calabria di Negrar • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Real-World watch: is zavicefta safe for tough infections?
Knowledge-focused Recruiting nowThis study observes 600 patients in Korea who receive Zavicefta for complicated abdominal or urinary tract infections or hospital-acquired pneumonia. Researchers track side effects and how well the drug works. It is required by Korean regulators to ensure the drug's safety after …
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:53 UTC